Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$597.00NASDAQ Previous Close - Last Trade as of 3:59PM ET 6/05/20

Today's Change-1.54(0.26%)
Bid (Size)$590.01 (1)
Ask (Size)$596.00 (1)
Day Low / High$578.43 - 600.14
Volume1.3 M

Insider Trends: Regeneron Pharmaceuticals Insider Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected

4:05PM ET 4/08/2020 MT Newswires
On Apr 06, 2020, EVP Finance CFO, Robert E Landry, exercised options/derivative securities for 3,000 shares. A portion of these optioned shares (2,304 shares) were sold for tax obligations and an additional 3,000 shares were sold for $1,498,155. After the Form 4 filing with the SEC, Landry has control over 24,545 shares of the company of which 24,373 shares are held directly and 172 are controlled indirectly. These holdings have an approximate market value of $12.3 million as of the prior-day closing price. In addition the company has granted Landry stock options of which 42,500 are currently in the money and have an approximate value of $9,724,425 as of yesterday's closing price.

During the most recent 90-day period, previous to the date of this filing, there have been 40 insider transactions reported to the SEC for Regeneron Pharmaceuticals. These transactions came from the activities of 13 different insiders that resulted in a net disposition of 258,737 company shares. Relative to the preceding 90-day window of time, there were 50 transactions from 19 insiders that resulted in the net acquisition of 1,353,202 shares.

This is lower than the average level of insider transactions in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Activity in the peer group averaged 45.7 transactions per company, with company insiders acquiring on average 19,365 shares.

SEC Story Link